Form 4: Belite Bio CFO Sells Shares
Insider Transaction (Form 4)
Hao-Yuan Chuang, Chief Financial Officer and a Director of Belite Bio, Inc, sold 367 shares of common stock on August 12, 2026.
Summary
- Open-market sale: disposed of 144 American depositary share at $180.00 ($25,920) on August 12, 2026; holds 93,656 after (Direct).
- Open-market sale: disposed of 223 American depositary share at $180.57 ($40,267) on August 12, 2026; holds 93,433 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $66,187 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Hao-Yuan Chuang — Director, Officer (Chief Financial Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-12 | Open-market sale | American depositary share | 144 | $180 | $25.9K | 93,656 |
| 2026-08-12 | Open-market sale | American depositary share | 223 | $181 | $40.3K | 93,433 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-12 | Open-market sale (144 shares) |
| 2026-08-12 | Open-market sale (223 shares) |
Keywords
insider transaction, Form 4, BLTE, BELITE BIO, INC, bearish, Hao-Yuan Chuang
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.